(RS)-baclofen

( DrugBank: Baclofen / KEGG DRUG: Baclofen )

1 disease

ID	Disease name (Link within this page)	Number of trials
10	Charcot-Marie-Tooth disease	7

10. Charcot-Marie-Tooth disease

Clinical trials : 41 / Drugs : 46 - (DrugBank : 9) / Drug target genes : 11 - Drug target pathways : 15

trials per page:

Showing 1 to 7 of 7 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-004805-30-DK (EUCTR)	31/01/2022	08/06/2021	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	350	Phase 3	France;United States;Canada;Spain;Belgium;Denmark;Israel;Netherlands;Germany;Italy
2	EUCTR2020-004805-30-NL (EUCTR)	23/09/2021	27/05/2021	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	350	Phase 3	France;United States;Canada;Spain;Belgium;Denmark;Israel;Germany;Netherlands;Italy
3	EUCTR2020-004805-30-ES (EUCTR)	04/05/2021	30/07/2021	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	350	Phase 3	France;United States;Canada;Belgium;Spain;Denmark;Israel;Netherlands;Germany;Italy
4	EUCTR2020-004805-30-FR (EUCTR)	04/05/2021	19/01/2022	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	350	Phase 3	United States;France;Canada;Spain;Belgium;Denmark;Israel;Netherlands;Germany;Italy
5	NCT04762758 (ClinicalTrials.gov)	March 30, 2021	17/2/2021	Phase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients	A Multi-center, Randomized, Double-blind, Placebo Controlled Phase III Study to Assess the Efficacy, ...	Charcot-Marie-Tooth Disease	Drug: (RS)-baclofen, naltrexone hydrochloride and D-sorbitol;Drug: Placebo	Pharnext SA	Worldwide Clinical Trials	Active, not recruiting	16 Years	65 Years	All	350	Phase 3	United States;Belgium;Canada;Denmark;France;Germany;Israel;Italy;Spain;Netherlands
6	EUCTR2020-004805-30-BE (EUCTR)		04/03/2021	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	NA			Female: yes Male: yes	387	Phase 3	France;United States;Canada;Spain;Belgium;Denmark;Israel;Netherlands;Germany;Italy
7	EUCTR2020-004805-30-DE (EUCTR)		05/02/2021	Phase 3 trial of PXT3003 in Charcot-Marie-Tooth (CMT) Type 1A patients	A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Assess the Efficacy, ...	Charcot Marie Tooth Type 1A MedDRA version: 20.0;Level: LLT;Classification code 10008414;Term: Charc ...	Product Name: NA Product Code: PXT3003 INN or Proposed INN: BACLOFEN Other descriptive name: (RS)-baclo ...	Pharnext SA	NULL	NA			Female: yes Male: yes	387	Phase 3	France;United States;Canada;Belgium;Spain;Denmark;Israel;Netherlands;Germany;Italy

First Previous1Next Last